[1] Liu X, Chen Z, Yu J, et al. MicroRNA profiling and head and neck cancer[J]. Comp Funct Genomics, 2009:837514.
[2] Dale TC. Signal transduction by the Wnt family of ligands[J]. Biochem J, 1998, 329 ( Pt 2):209-223.
[3] You Z, Saims D, Chen S, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis[J]. J Cell Biol, 2002, 157(3): 429-440.
[4] Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer[J]. Nat Rev Cancer, 2008, 8(5): 387-398.
[5] 宋晓陵. 口腔组织病理学[M]. 第2版. 北京:人民卫生出版社, 2003:211.
[6] Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer[J]. Nat Rev Cancer, 2013, 13(1): 11-26.
[7] Gurbuz I, Chiquet-Ehrismann R. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer[J]. Int J Biochem Cell Biol, 2015, 62:142-146.
[8] Ji J, Jia S, Ji K, et al. Wnt1 inducible signalling pathway protein-2 (WISP2/CCN5): roles and regulation in human cancers (review)[J]. Oncol Rep, 2014, 31(2):533-539.
[9] Polakis P. Wnt signaling in cancer[J]. Cold Spring Harb Perspect Biol, 2012, 4(5):1-10.
[10] Chen G, Shukeir N, Potti A, et al. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications[J]. Cancer, 2004, 101(6):1345-1356.
[11] Reya T, Clevers H. Wnt signalling in stem cells and cancer[J]. Nature, 2005, 434(7035):843-850.
[12] Howe LR, Subbaramaiah K, Chung WJ, et al. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells[J]. Cancer Res, 1999, 59(7):1572-1577.
[13] Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer[J]. Nat Genet, 2004, 36(4):417-422.
[14] Wang JM, Huang FC, Kuo MH, et al. Inhibition of cancer cell migration and invasion through suppressing the Wnt1-mediating signal pathway by G-quadruplex structure stabilizers[J]. J Biol Chem, 2014, 289(21):14612-14623.
[15] Veeck J, Dahl E. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3[J]. Biochim Biophy Acta, 2012, 1825(1):18-28.
[16] Wang Y, Krivtsov AV, Sinha AU, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML[J]. Science, 2010, 327(5973): 1650-1653.
[17] Monteiro J, Gaspar C, Richer W, et al. Cancer stemness in Wnt-driven mammary tumorigenesis[J]. Carcinogenesis, 2014, 35(1):2-13. |